Zoster sine herpete following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient

Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Lee, 2022, Herpes zoster reactivation after mRNA-1273 vaccination in patients with rheumatic diseases, Ann Rheum Dis, 81, 595, 10.1136/annrheumdis-2021-221688 Katsikas Triantafyllidis, 2021, Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports, Vaccines, 9, 1013, 10.3390/vaccines9091013 May Lee, 2022, Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination, J Cosmet Dermatol, 21, 1347, 10.1111/jocd.14871 Birabaharan, 2021, Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: a cohort study, J Am Acad Dermatol Kennedy, 2018, Clinical features of varicella-zoster virus infection, Viruses, 10, 10.3390/v10110609 Iwanaga, 2022, A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination, Clin Anat, 35, 45, 10.1002/ca.23790 Chapin-Bardales, 2021, Reactogenicity following receipt of mRNA-based COVID-19 vaccines, JAMA, 325, 2201, 10.1001/jama.2021.5374 Blumenthal, 2011, Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF, Neurology, 76, 484, 10.1212/WNL.0b013e31820a0d28 Zhou, 2020, Zoster sine herpete: a review, Korean J Pain, 33, 208, 10.3344/kjp.2020.33.3.208 Johnson, 2014, Clinical practice. Postherpetic neuralgia, N Engl J Med, 371, 1526, 10.1056/NEJMcp1403062